Medical Devices; Ear, Nose, and Throat Devices; Classification of the Transcutaneous Electrical Nerve Stimulator for the Relief of Congestion
fda-device · Food and Drug Administration · Rule · Published 2026-04-16 · Effective 2026-04-16 · 91 FR 20348
Document
Document number
2026-07365
Federal Register citation
91 FR 20348
CFR reference
21 CFR 874
Type
Rule
Action
Final amendment; final order.
Category
fda-device
Sub-agency
Food and Drug Administration
Publication date
2026-04-16
Effective date
2026-04-16
HHS docket
Docket No. FDA-2026-N-2959
Abstract
The Food and Drug Administration (FDA, the Agency, or we) is classifying the transcutaneous electrical nerve stimulator for the relief of congestion into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the transcutaneous electrical nerve stimulator for the relief of congestion. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.